Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TT-173 in skin graft donor sites
NCT02012569Phase 2Completed
- Sponsor
- Thrombotargets Europe
- Start
- Nov 2013
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TT-173, sponsored by Thrombotargets Europe. Started Nov 2013; status: completed.
02
Drugs
TT-173
Beyond the preview
Go deeper on NCT02012569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012569.